🇺🇸 FDA
Patent

US 10767184

Chimeric antigen receptors targeting B-cell maturation antigen

granted A61KA61K2039/505A61K48/00

Quick answer

US patent 10767184 (Chimeric antigen receptors targeting B-cell maturation antigen) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
59
CPC classes
A61K, A61K2039/505, A61K48/00, A61P, A61P35/00